
Sign up to save your podcasts
Or
Neuralink gets approval to start human trials in Canada, The New York Times says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti. It has a medical use. It's Thursday, November 22nd and this is Engadget News.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
4.6
1717 ratings
Neuralink gets approval to start human trials in Canada, The New York Times says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti. It has a medical use. It's Thursday, November 22nd and this is Engadget News.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
6,068 Listeners
1,279 Listeners
1,632 Listeners
1,051 Listeners
805 Listeners
871 Listeners
1,752 Listeners
8,599 Listeners
383 Listeners
1,360 Listeners
137 Listeners
1,440 Listeners
38 Listeners
5,352 Listeners
162 Listeners